|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustment to reconcile net loss to net cash used in operating activities: | ||||
| Dividend income received in Trust Account | ||||
| Changes in operating assets and liabilities: | ||||
| Accrued liabilities | ||||
| Administrative service fee payable - related party | ||||
| Prepaid expenses | ||||
| Net cash used in operating activities | ||||
| Cash flows from investing activities: | ||||
| Proceeds from sales of marketable securities in Trust Account | ||||
| Cash deposited in trust account | ||||
| Withdrawals from cash and cash equivalents in Trust Account | ||||
| Cash deposited in Trust Account for monthly extension fees | ||||
| Net cash provided by investing activities | ||||
| Cash flows from financing activities: | ||||
| Proceed from related party loan | ||||
| Proceed from convertible promissory note - related party | ||||
| Proceed from convertible promissory notes - related party | ||||
| Repayment of related party loans | ||||
| Payment for redemption of Ordinary Shares | ||||
| Net cash (used in) provided by financing activities | ||||
| Net decrease in cash | ||||
| Cash – beginning of the period | ||||
| Cash – end of the period | ||||
| Non-cash investing and financial activities: | ||||
| Remeasurement adjustment on Public Shares subject to possible redemption | ||||
Loading...